Peter K.  Shagory net worth and biography

Peter Shagory Biography and Net Worth

EVP of CONMED
Peter K. Shagory is the Exec. VP of Strategy & Corp. Devel. at Conmed.

What is Peter K. Shagory's net worth?

The estimated net worth of Peter K. Shagory is at least $122,416.58 as of April 28th, 2023. Mr. Shagory owns 1,861 shares of CONMED stock worth more than $122,417 as of April 28th. This net worth approximation does not reflect any other assets that Mr. Shagory may own. Learn More about Peter K. Shagory's net worth.

How old is Peter K. Shagory?

Mr. Shagory is currently 55 years old. There are 8 older executives and no younger executives at CONMED. The oldest executive at CONMED is Mr. David R. Murray, President of ConMed Electrosurgery, who is 76 years old. Learn More on Peter K. Shagory's age.

How do I contact Peter K. Shagory?

The corporate mailing address for Mr. Shagory and other CONMED executives is 525 FRENCH ROAD, UTICA NY, 13502. CONMED can also be reached via phone at (727) 392-6464. Learn More on Peter K. Shagory's contact information.

Has Peter K. Shagory been buying or selling shares of CONMED?

Peter K. Shagory has not been actively trading shares of CONMED during the past quarter. Most recently, Peter K. Shagory sold 2,442 shares of the business's stock in a transaction on Friday, April 28th. The shares were sold at an average price of $128.00, for a transaction totalling $312,576.00. Following the completion of the sale, the executive vice president now directly owns 1,861 shares of the company's stock, valued at $238,208. Learn More on Peter K. Shagory's trading history.

Who are CONMED's active insiders?

CONMED's insider roster includes Pat Beyer (Insider), Brian Concannon (Director), Todd Garner (CFO), Curt Hartman (CEO), Daniel Jonas (Insider), John Kennedy (EVP), Stanley Peters, III (VP), Peter Shagory (EVP), and Mark Tryniski (Director). Learn More on CONMED's active insiders.

Are insiders buying or selling shares of CONMED?

In the last twelve months, insiders at the sold shares 13 times. They sold a total of 55,398 shares worth more than $6,911,799.58. The most recent insider tranaction occured on December, 4th when insider Stanley W Peters III sold 2,300 shares worth more than $252,839.00. Insiders at CONMED own 6.8% of the company. Learn More about insider trades at CONMED.

Information on this page was last updated on 12/4/2023.

Peter K. Shagory Insider Trading History at CONMED

Transaction DateBuy/SellNumber of SharesAverage Share PriceTotal TransactionShares Held After TransactionDetails
4/28/2023Sell2,442$128.00$312,576.001,861View SEC Filing Icon  
See Full Table

Peter K. Shagory Buying and Selling Activity at CONMED

This chart shows Peter K Shagory's buying and selling at CONMED by year and by quarter.

Skip ChartChart Data in Insider Trading History Table

CONMED Company Overview

CONMED logo
CONMED Corporation, a medical technology company, develops, manufactures, and sells surgical devices and related equipment for surgical procedures worldwide. The company offers orthopedic surgery products, including BioBrace, TruShot with Y-Knot All-In-One Soft Tissue Fixation System, Y-knot All-Suture Anchors, and Agro Knotless Suture Anchors, which provide clinical solutions to orthopedic surgeons for the augmentation and repair of soft tissue injuries, as well as provides supporting products that enable surgeons to perform minimally invasive sports medicine surgeries. It markets orthopedic surgery products under the Hall, CONMED Linvatec, Concept, and Shutt brands. The company also provides battery-powered and autoclavable bone power tool systems for use in orthopedic, arthroscopic, oral/maxillofacial, podiatric, spinal, and cardiothoracic surgeries under Hall surgical brand name. In addition, it offers general surgery products, including clinical insufflation systems under AirSeal brand; smoke removal devices under Buffalo Filter brand; endomechanical products, such as tissue retrieval bags, trocars, suction irrigation devices, graspers, scissors, and dissectors used in minimally invasive surgeries; and electrosurgical solution comprising monopolar and bipolar generators, argon beam coagulation generators, handpieces, smoke management systems and other accessories. Further, the company provides endoscopic technologies, including therapeutic and diagnostic products for use in gastroenterology procedures, and products for the treatment of diseases of the dilatation, hemostasis, biliary, structure management, and infection prevention and patient monitoring, including ECG and EEG electrodes, and cardiac defibrillation pads. It markets its products directly to hospitals, surgery centers, and other healthcare institutions, as well as through medical specialty distributors. CONMED Corporation was incorporated in 1970 and is headquartered in Largo, Florida.
Read More

Today's Range

Now: $65.78
Low: $62.00
High: $66.25

50 Day Range

MA: $78.06
Low: $61.90
High: $85.82

2 Week Range

Now: $65.78
Low: $61.05
High: $138.47

Volume

1,135,843 shs

Average Volume

573,520 shs

Market Capitalization

$2.03 billion

P/E Ratio

25.20

Dividend Yield

1.22%

Beta

1.33